Low impact
AbbVie stock rose after announcing an acquisition that could bring new drugs into its pipeline.
Finnhub06/23, 10:18 AM
Related assets
Coming up for ABBV
Explore next
Latest ABBV news
FirstSquawk08/20, 09:57 AM
Piper Sandler raised its price target on AbbVie to $303 from $298.
Bloomberg08/17, 06:28 PM
Bloomberg08/03, 04:58 PM